This month, the European Parliament’s Committee on the Environment, Public Health and Food Safety released a draft report on fraud in the EU food chain. Although the incidence of food fraud is increasing, the EU has no framework in place to address it and methods for dealing with it vary widely among member states. The […]
For the one thousand public companies that spend the most on R&D, R&D spending increased 5.8% in fiscal 2013 (the fiscal year ending prior to June 30) to $638 billion, down from 9.6% last year. The total share of revenues spent on R&D increased from 3.43% to 3.60%. Computing and electronics, health care, automotive, industrials, […]
Immunotherapy drugs, known as immune checkpoint inhibitors, could revolutionize cancer treatment and become a major drug market. Bristol-Myers Squibb, Merck & Co. and Roche are among the firms developing such drugs, which use the immune system to target tumor cells. Yervoy, made by Bristol-Myers, the market leader, is approved for treating melanoma, but shows potential […]
Chelmsford, MA 10/2/13—Spectro Inc., a developer of instrumentation and software for the industrial performance fluids market, has acquired Wilks Enterprise for an undisclosed amount. Wilks specializes in the development and manufacture of mid-IR application-specific analyzers that are used for biofuel, petrochemical, environmental, quality control, manufacturing and ambient air monitoring measurements. “Wilks has built an excellent […]
Los Angeles, CA 10/14/13—Affymetrix has sold its Anatrace business to StoneCalibre, an investment firm specializing in the acquisition of lower middle market companies, for an undisclosed amount. Anatrace develops, manufactures and distributes high purity detergents and synthetic lipids for use in membrane protein studies. “Anatrace is a high quality company offering a value-add product that […]
Heysham, UK 9/16/13—Research chemicals provider Alfa Aesar has bought Biomedical Technologies (BTI). BTI product lines include specialty proteins, cell culture additives and immunoassay tools. “The acquisition of BTI brings protein research and characterization, all types of profiling tools and certain separation technologies and provides opportunities for Alfa Aesar to leverage BTI’s manufacturing capabilities to enhance […]
Kobe, Japan 9/24/13—Diagnostics firm Sysmex has acquired Partec, a German provider of flow cytometers for research and diagnostic applications, for an undisclosed amount. Sysmex plans to leverage its sales and support network to increase Partec sales, as well as combine flow cytometry with its hematology offerings. In fiscal 2012, Partec had sales of €20.1 million […]
Newton, NJ and Westwood, MA 10/7/13—Photonics product manufacturer Thorlabs has acquired CompuCyte, the supplier of the Laser Scanning Cytometry technology for high content cellular and tissue-based analysis, for an undisclosed amount. CompuCyte’s iCyte, iCys and iColor instruments incorporate non-confocal laser scanner imaging technology. “The acquisition of the CompuCyte product lines is an important step forward […]
Aubagne, France 10/7/13—Sartorius Stedim Biotech has made a cash offer to acquire UK-based TAP Biosystems. The offer values the equity of TAP at approximately €33 million ($45 million = €0.74 = $1). TAP designs and develops small scale, multi-parallel fermentation systems, automated cell processing systems and other benchtop equipment. “Adding capabilities in the early steps […]
Tokyo, Japan and New York, NY 9/27/13; Osaka, Japan 9/27/13—Panasonic has agreed to sell its Healthcare business to investment firm Kohlberg Kravis Roberts & Co. (KKR) for approximately $1.67 billion. Following the sale, Panasonic will purchase 20% of outstanding shares in the new company. Panasonic Healthcare consists of three businesses: In Vitro Diagnostics, Medicom and […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
